Evidence map›Paper›PMID 38044944›Full record

SynthesisFrontiers in pharmacology2023

An updated meta-analysis of Chinese herbal medicine for the prevention of COVID-19 based on Western-Eastern medicine.

Siying Hu, Dan Luo, Qikui Zhu, Jie Pan, Bonan Chen, Michael Furian, Harsh Vivek Harkare, Shoukai Sun, Adel Fansa, Xiaoping Wu and 4 more

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Siying HuChengdu University of Traditional Chinese Medicine, Chengdu, China.
Dan LuoChengdu University of Traditional Chinese Medicine, Chengdu, China.
Qikui ZhuDepartment of Biomedical Engineering and Computer and Data Science, Case Western Reserve University, Cleveland, OH, United States.
Jie PanDepartment of Pathology, Stanford University School of Medicine, Palo Alto, CA, United States.
Bonan ChenDepartment of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Michael FurianResearch Department, Swiss University of Traditional Chinese Medicine, Bad Zurzach, Switzerland.
Harsh Vivek HarkareDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.
Shoukai SunDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.
Adel FansaCharité Universitätsmedizin Berlin, Berlin, Germany.
Xiaoping WuNational Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Baili YuChengdu University of Traditional Chinese Medicine, Chengdu, China.
Tianhong MaChengdu University of Traditional Chinese Medicine, Chengdu, China.
Fei WangChengdu University of Traditional Chinese Medicine, Chengdu, China.
Shihua Shi *Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chinese herbal medicineCOVID-19immunitymeta-analysispreventionWE medicine

Identifiers

PMID38044944
PMCPMC10693348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.